C. elegans: Model host and tool for antimicrobial drug discovery

DMM Disease Models and Mechanisms

Volumn 4, Issue 3, 2011, Pages 300-304

  Ewbank, Jonathan J ^a,b,c   Zugasti, Olivier ^a,b,c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c CNRS UMR6102   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBACTERIAL FACTOR PEPTIDE; ANTIINFECTIVE AGENT; CAENACIN; CAENOPORE; CAENORHABDITIS ELEGANS PROTEIN; LECTIN; LYSOZYME; NEUROPEPTIDE LIKE PROTEIN; NEW DRUG; PEXIGANAN ACETATE; POLYPEPTIDE ANTIBIOTIC AGENT; SPHINGOLIPID ACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

CAENORHABDITIS ELEGANS; DIABETIC FOOT; DRUG DEVELOPMENT; DRUG SCREENING; HOST; IMMUNE SYSTEM; IN VIVO STUDY; INNATE IMMUNITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW;

ANIMALS; ANTI-INFECTIVE AGENTS; CAENORHABDITIS ELEGANS; CAENORHABDITIS ELEGANS PROTEINS; DRUG DISCOVERY; HUMANS; MODELS, ANIMAL;

CAENORHABDITIS ELEGANS;

EID: 79956108860     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.006684     Document Type: Review

References (46)

1. Aballay, A., Yorgey, P. and Ausubel, F. M. (2000). Salmonella typhimurium proliferates and establishes a persistent infection in the intestine of Caenorhabditis elegans. Curr. Biol. 10, 1539-1542.
2. Alegado, R. and Tan, M. (2008). Resistance to antimicrobial peptides contributes to persistence of Salmonella typhimurium in the C. elegans intestine. Cell. Microbiol. 10, 1259-1273.
3. Alper, S., McBride, S. J., Lackford, B., Freedman, J. H. and Schwartz, D. A. (2007). Specificity and complexity of the Caenorhabditis elegans innate immune response. Mol. Cell. Biol. 27, 5544-5553.
4. Banyai, L. and Patthy, L. (1998). Amoebapore homologs of Caenorhabditis elegans. Biochim. Biophys. Acta 1429, 259-264.
5. Breger, J., Fuchs, B. B., Aperis, G., Moy, T. I., Ausubel, F. M. and Mylonakis, E. (2007). Antifungal chemical compounds identified using a C. elegans pathogenicity assay. PLoS Pathog. 3, e18.
6. Bush, K. (2010). Alarming beta-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr. Opin. Microbiol. 13, 558-564.
7. Couillault, C., Pujol, N., Reboul, J., Sabatier, L., Guichou, J. F., Kohara, Y. and Ewbank, J. J. (2004). TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM. Nat. Immunol. 5, 488-494.
8. Darby, C. (2005). Interactions with microbial pathogens. In WormBook: The C. elegans Research Community. doi/10.1895/wormbook.1.21.1, http://www.wormbook.org.
9. Doitsidou, M., Poole, R. J., Sarin, S., Bigelow, H. and Hobert, O. (2010). C. elegans mutant identification with a one-step whole-genome-sequencing and SNP mapping strategy. PLoS One 5, e15435.
10. Evans, E. A., Kawli, T. and Tan, M. W. (2008). Pseudomonas aeruginosa suppresses host immunity by activating the DAF-2 insulin-like signaling pathway in Caenorhabditis elegans. PLoS Pathog. 4, e1000175.
11. Fekete, C., Tholander, M., Rajashekar, B., Ahren, D., Friman, E., Johansson, T. and Tunlid, A. (2008). Paralysis of nematodes: shifts in the transcriptome of the nematode-trapping fungus Monacrosporium haptotylum during infection of Caenorhabditis elegans. Environ. Microbiol. 10, 364-375.
12. Hillier, L. W., Reinke, V., Green, P., Hirst, M., Marra, M. A. and Waterston, R. H. (2009). Massively parallel sequencing of the polyadenylated transcriptome of C. elegans. Genome Res. 19, 657-666.
13. Hodgkin, J., Kuwabara, P. E. and Corneliussen, B. (2000). A novel bacterial pathogen, Microbacterium nematophilum, induces morphological change in the nematode C. elegans. Curr. Biol. 10, 1615-1618.
14. Ideo, H., Fukushima, K., Gengyo-Ando, K., Mitani, S., Dejima, K., Nomura, K. and Yamashita, K. (2009). A Caenorhabditis elegans glycolipid-binding galectin functions in host defense against bacterial infection. J. Biol. Chem. 284, 26493-26501.
15. Irazoqui, J. E., Urbach, J. M. and Ausubel, F. M. (2010). Evolution of host innate defence: insights from Caenorhabditis elegans and primitive invertebrates. Nat. Rev. Immunol. 10, 47-58.
16. Kato, Y., Aizawa, T., Hoshino, H., Kawano, K., Nitta, K. and Zhang, H. (2002). abf-1 and abf-2, ASABF-type antimicrobial peptide genes in Caenorhabditis elegans. Biochem. J. 361, 221-230.
17. Kurz, C. L. and Ewbank, J. J. (2007). Infection in a dish: high-throughput analyses of bacterial pathogenesis. Curr. Opin. Microbiol. 10, 10-16.
18. Labrousse, A., Chauvet, S., Couillault, C., Kurz, C. L. and Ewbank, J. J. (2000). Caenorhabditis elegans is a model host for Salmonella typhimurium. Curr. Biol. 10, 1543-1545.
19. Lamitina, T. (2006). Functional genomic approaches in C. elegans. Methods Mol. Biol. 351, 127-138.
20. Leippe, M. (1999). Antimicrobial and cytolytic polypeptides of amoeboid protozoa-effector molecules of primitive phagocytes. Dev. Comp. Immunol. 23, 267-279.
21. Mallo, G. V., Kurz, C. L., Couillault, C., Pujol, N., Granjeaud, S., Kohara, Y. and Ewbank, J. J. (2002). Inducible antibacterial defense system in C. elegans. Curr. Biol. 12, 1209-1214.
22. Means, T. K., Mylonakis, E., Tampakakis, E., Colvin, R. A., Seung, E., Puckett, L., Tai, M. F., Stewart, C. R., Pukkila-Worley, R., Hickman, S. E. et al. (2009). Evolutionarily conserved recognition and innate immunity to fungal pathogens by the scavenger receptors SCARF1 and CD36. J. Exp. Med. 206, 637-653.
23. Millet, A. C. and Ewbank, J. J. (2004). Immunity in Caenorhabditis elegans. Curr. Opin. Immunol. 16, 4-9.
24. Moy, T. I., Ball, A. R., Anklesaria, Z., Casadei, G., Lewis, K. and Ausubel, F. M. (2006). Identification of novel antimicrobials using a live-animal infection model. Proc. Natl. Acad. Sci. USA 103, 10414-10419.
25. Moy, T. I., Conery, A. L., Larkins-Ford, J., Wu, G., Mazitschek, R., Casadei, G., Lewis, K., Carpenter, A. E. and Ausubel, F. M. (2009). High-throughput screen for novel antimicrobials using a whole animal infection model. ACS Chem. Biol. 4, 527-533.
26. Muir, R. E. and Tan, M. W. (2008). Virulence of Leucobacter chromiireducens subsp. solipictus to Caenorhabditis elegans: characterization of a novel host-pathogen interaction. Appl. Environ. Microbiol. 74, 4185-4198.
27. Nemoto-Sasaki, Y., Hayama, K., Ohya, H., Arata, Y., Kaneko, M. K., Saitou, N., Hirabayashi, J. and Kasai, K. (2008). Caenorhabditis elegans galectins LEC-1-LEC-11: structural features and sugar-binding properties. Biochim. Biophys. Acta 1780, 1131-1142.
28. Nicholas, H. R. and Hodgkin, J. (2004). The ERK MAP kinase cascade mediates tail swelling and a protective response to rectal infection in C. elegans. Curr. Biol. 14, 1256-1261.
29. O'Rourke, D., Baban, D., Demidova, M., Mott, R. and Hodgkin, J. (2006). Genomic clusters, putative pathogen recognition molecules, and antimicrobial genes are induced by infection of C. elegans with M. nematophilum. Genome Res. 16, 1005-1016. (Pubitemid 44162260)
30. Okoli, I., Coleman, J. J., Tampakakis, E., An, W. F., Holson, E., Wagner, F., Conery, A. L., Larkins-Ford, J., Wu, G., Stern, A. et al. (2009). Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay. PLoS One 4, e7025.
31. Powell, J. R. and Ausubel, F. M. (2008). Models of Caenorhabditis elegans infection by bacterial and fungal pathogens. In Methods in Molecular Biology (ed. J. Ewbank and E. Vivier), pp. 403-427. New York: Humana Press.
32. Pradel, E., Zhang, Y., Pujol, N., Matsuyama, T., Bargmann, C. I. and Ewbank, J. J. (2007). Detection and avoidance of a natural product from the pathogenic bacterium Serratia marcescens by Caenorhabditis elegans. Proc. Natl. Acad. Sci. USA 104, 2295-2300.
33. Pujol, N., Zugasti, O., Wong, D., Couillault, C., Kurz, C. L., Schulenburg, H. and Ewbank, J. J. (2008). Antifungal innate immunity in C. elegans is enhanced by evolutionary diversification of antimicrobial peptides. PLoS Pathog. 4, e1000105.
34. Roeder, T., Stanisak, M., Gelhaus, C., Bruchhaus, I., Grotzinger, J. and Leippe, M. (2010). Caenopores are antimicrobial peptides in the nematode Caenorhabditis elegans instrumental in nutrition and immunity. Dev. Comp. Immunol. 34, 203-209.
35. Schulenburg, H. and Boehnisch, C. (2008). Diversification and adaptive sequence evolution of Caenorhabditis lysozymes (Nematoda: Rhabditidae). BMC Evol. Biol. 8, 114.
36. Schulenburg, H., Hoeppner, M. P., Weiner, J., 3rd and Bornberg-Bauer, E. (2008). Specificity of the innate immune system and diversity of C-type lectin domain (CTLD) proteins in the nematode Caenorhabditis elegans. Immunobiology 213, 237-250.
37. Shapira, M., Hamlin, B. J., Rong, J., Chen, K., Ronen, M. and Tan, M. W. (2006). A conserved role for a GATA transcription factor in regulating epithelial innate immune responses. Proc. Natl. Acad. Sci. USA 103, 14086-14091.
38. Sifri, C. D., Begun, J. and Ausubel, F. M. (2005). The worm has turned-microbial virulence modeled in Caenorhabditis elegans. Trends Microbiol. 13, 119-127.
39. Swem, L. R., Swem, D. L., O'Loughlin, C. T., Gatmaitan, R., Zhao, B., Ulrich, S. M. and Bassler, B. L. (2009). A quorum-sensing antagonist targets both membrane-bound and cytoplasmic receptors and controls bacterial pathogenicity. Mol. Cell 35, 143-153.
40. Tan, M. W., Mahajan-Miklos, S. and Ausubel, F. M. (1999a). Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc. Natl. Acad. Sci. USA 96, 715-720.
41. Tan, M. W., Rahme, L. G., Sternberg, J. A., Tompkins, R. G. and Ausubel, F. M. (1999b). Pseudomonas aeruginosa killing of Caenorhabditis elegans used to identify P. aeruginosa virulence factors. Proc. Natl. Acad. Sci. USA 96, 2408-2413.
42. Troemel, E. R., Chu, S. W., Reinke, V., Lee, S. S., Ausubel, F. M. and Kim, D. H. (2006). p38 MAPK regulates expression of immune response genes and contributes to longevity in C. elegans. PLoS Genet. 2, e183.
43. Uccelletti, D., Zanni, E., Marcellini, L., Palleschi, C., Barra, D. and Mangoni, M. L. (2010). Anti-Pseudomonas activity of frog skin antimicrobial peptides in a Caenorhabditis elegans infection model: a plausible mode of action in vitro and in vivo. Antimicrob. Agents Chemother. 54, 3853-3860.
44. Wong, D., Bazopoulou, D., Pujol, N., Tavernarakis, N. and Ewbank, J. J. (2007). Genome-wide investigation reveals pathogen-specific and shared signatures in the response of Caenorhabditis elegans to infection. Genome Biol. 8, R194.
45. Zhang, H., Yoshida, S., Aizawa, T., Murakami, R., Suzuki, M., Koganezawa, N., Matsuura, A., Miyazawa, M., Kawano, K., Nitta, K. et al. (2000). In vitro antimicrobial properties of recombinant ASABF, an antimicrobial peptide isolated from the nematode Ascaris suum. Antimicrob. Agents Chemother. 44, 2701-2705.
46. Zugasti, O. and Ewbank, J. J. (2009). Neuroimmune regulation of antimicrobial peptide expression by a noncanonical TGF-beta signaling pathway in Caenorhabditis elegans epidermis. Nat. Immunol. 10, 249-256.